Condition: Li-Fraumeni Syndrome · TP53 Gene Mutation · Hereditary Cancer Syndrome · Sponsor: Dana-Farber Cancer Institute
The purpose of this research study is to learn more about variants in the TP53 gene both associated with Li-Fraumeni Syndrome (LFS), a hereditary cancer risk condition, and TP53 variants found in the blood for other reasons (e.g. ACE/CHIP and mosaicism).
This description comes directly from the study's public registry record.
Judy E Garber, MD, MPH · 617-632-5770 · jegarber@partners.org
Sophie Cahill, BS · 617-632-4795 · Sophie_Cahill@DFCI.HARVARD.edu
Always discuss trial participation with your own doctor first.
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
| Judy E. Garber | Boston, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04541654